Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 406

1.

Selection and persistence of viral resistance in HIV-infected children after exposure to single-dose nevirapine.

Martinson NA, Morris L, Gray G, Moodley D, Pillay V, Cohen S, Dhlamini P, Puren A, Bhayroo S, Steyn J, McIntyre JA.

J Acquir Immune Defic Syndr. 2007 Feb 1;44(2):148-53.

PMID:
17117145
2.

Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012).

Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB.

AIDS. 2001 Oct 19;15(15):1951-7.

PMID:
11600822
3.

Sensitive drug-resistance assays reveal long-term persistence of HIV-1 variants with the K103N nevirapine (NVP) resistance mutation in some women and infants after the administration of single-dose NVP: HIVNET 012.

Flys T, Nissley DV, Claasen CW, Jones D, Shi C, Guay LA, Musoke P, Mmiro F, Strathern JN, Jackson JB, Eshleman JR, Eshleman SH.

J Infect Dis. 2005 Jul 1;192(1):24-9. Epub 2005 Jun 1.

PMID:
15942890
4.

Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.

van Zyl GU, Claassen M, Engelbrecht S, Laten JD, Cotton MF, Theron GB, Preiser W.

J Med Virol. 2008 Jun;80(6):942-6. doi: 10.1002/jmv.21157.

PMID:
18428139
5.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
6.

Antiretroviral resistance patterns and HIV-1 subtype in mother-infant pairs after the administration of combination short-course zidovudine plus single-dose nevirapine for the prevention of mother-to-child transmission of HIV.

Chalermchockcharoenkit A, Culnane M, Chotpitayasunondh T, Vanprapa N, Leelawiwat W, Mock PA, Asavapiriyanont S, Teeraratkul A, McConnell MS, McNicholl JM, Tappero JW.

Clin Infect Dis. 2009 Jul 15;49(2):299-305. doi: 10.1086/599612.

PMID:
19522656
7.

Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.

Johnson JA, Li JF, Morris L, Martinson N, Gray G, McIntyre J, Heneine W.

J Infect Dis. 2005 Jul 1;192(1):16-23. Epub 2005 Jun 1.

PMID:
15942889
8.

Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis.

Arrivé E, Newell ML, Ekouevi DK, Chaix ML, Thiebaut R, Masquelier B, Leroy V, Perre PV, Rouzioux C, Dabis F; Ghent Group on HIV in Women and Children.

Int J Epidemiol. 2007 Oct;36(5):1009-21. Epub 2007 May 28. Review.

PMID:
17533166
9.

Development of nevirapine resistance in infants is reduced by use of infant-only single-dose nevirapine plus zidovudine postexposure prophylaxis for the prevention of mother-to-child transmission of HIV-1.

Eshleman SH, Hoover DR, Hudelson SE, Chen S, Fiscus SA, Piwowar-Manning E, Jackson JB, Kumwenda NI, Taha TE.

J Infect Dis. 2006 Feb 15;193(4):479-81. Epub 2006 Jan 11.

PMID:
16425125
10.

Women exposed to single-dose nevirapine in successive pregnancies: effectiveness and nonnucleoside reverse transcriptase inhibitor resistance.

Martinson NA, Morris L, Johnson J, Gray GE, Pillay V, Ledwaba J, Dhlamini P, Cohen S, Puren A, Steyn J, Heneine W, McIntyre JA.

AIDS. 2009 Apr 27;23(7):809-16. doi: 10.1097/QAD.0b013e328323ad49.

PMID:
19287298
11.

Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapine.

Basson AE, Ntsala M, Martinson N, Tlale E, Corrigan GE, Shao X, Gray G, McIntyre J, Puren A, Morris L.

J Acquir Immune Defic Syndr. 2008 Dec 15;49(5):538-43. doi: 10.1097/QAI.0b013e31818d5dcf.

PMID:
18989222
12.

Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.

Jacob MS, Durairaj A, Vijayakumari J, Srijayanth P, Sivakumar MR.

Indian J Pathol Microbiol. 2011 Apr-Jun;54(2):359-61. doi: 10.4103/0377-4929.81637.

13.

Antiretroviral therapy for prevention of mother-to-child HIV transmission : focus on single-dose nevirapine.

Giaquinto C, Rampon O, De Rossi A.

Clin Drug Investig. 2006;26(11):611-27. Review.

PMID:
17163296
14.

Nevirapine resistance after single dose prophylaxis.

Eshleman SH, Jackson JB.

AIDS Rev. 2002 Apr-Jun;4(2):59-63. Review.

PMID:
12152519
15.

Response to antiretroviral therapy after a single, peripartum dose of nevirapine.

Lockman S, Shapiro RL, Smeaton LM, Wester C, Thior I, Stevens L, Chand F, Makhema J, Moffat C, Asmelash A, Ndase P, Arimi P, van Widenfelt E, Mazhani L, Novitsky V, Lagakos S, Essex M.

N Engl J Med. 2007 Jan 11;356(2):135-47.

16.

Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.

Pilger D, Hauser A, Kuecherer C, Mugenyi K, Kabasinguzi R, Somogyi S, Harms G, Kunz A.

Antivir Ther. 2011;16(1):109-13. doi: 10.3851/IMP1698.

PMID:
21311114
17.

Slower clearance of nevirapine resistant virus in infants failing extended nevirapine prophylaxis for prevention of mother-to-child HIV transmission.

Persaud D, Bedri A, Ziemniak C, Moorthy A, Gudetta B, Abashawl A, Mengistu Y, Omer SB, Isehak A, Kumbi S, Adamu R, Lulseged S, Ashworth R, Hassen E, Ruff A; Ethiopian Swen Study Team.

AIDS Res Hum Retroviruses. 2011 Aug;27(8):823-9. doi: 10.1089/AID.2010.0346. Epub 2011 Feb 25.

18.

Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.

Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.

Int J STD AIDS. 2009 Apr;20(4):249-54. doi: 10.1258/ijsa.2008.008480.

PMID:
19304969
19.

Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission.

Jackson JB, Becker-Pergola G, Guay LA, Musoke P, Mracna M, Fowler MG, Mofenson LM, Mirochnick M, Mmiro F, Eshleman SH.

AIDS. 2000 Jul 28;14(11):F111-5.

PMID:
10983633
20.

Low rate of emergence of nevirapine and lamivudine resistance after post-partum interruption of a triple-drug regimen.

Pérez H, Vignoles M, Laufer N, Gómez A, Coll P, Lottner J, Rolón M, Salomón H, Cahn P.

Antivir Ther. 2008;13(1):135-9.

PMID:
18389908

Supplemental Content

Support Center